Bernd-Jan Sanson is Vice President, Global Head of Medical Affairs. He is responsible for designing and implementing Prilenia’s global medical affairs strategy and developing robust medical engagement with Health Care Professionals, public health leaders and other key stakeholders. Bernd-Jan brings more than 25 years of experience working in the pharmaceutical industry. He has held leadership roles in clinical development and medical affairs at Sanofi Genzyme, Kiadis Pharma, CellPoint and most recently at Amylyx where he led the European ALS Medical Affairs team. Bernd-Jan has extensive experience in Rare Diseases, and more specifically in Rare Neurodegenerative Diseases, giving him a deep passion for working with the physician and patient communities to improve the lives of people living with these devastating diseases.

Bernd-Jan is a Medical Doctor and obtained his PhD from the Academic Medical Center of the University of Amsterdam in the Netherlands.

• 

  VP, Global Head of Medical Affairs in Prilenia

  Pursuing Hope. Leading With Science.